These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 26318295)
1. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells. Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295 [TBL] [Abstract][Full Text] [Related]
2. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer. Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p. Dong J; Wang Q; Li L; Xiao-Jin Z Cell Physiol Biochem; 2018; 45(5):2086-2094. PubMed ID: 29533945 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Qin X; Wan Y; Wang S; Xue M Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes. Yang F; Guo L; Cao Y; Li S; Li J; Liu M Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Chen Y; Ke G; Han D; Liang S; Yang G; Wu X Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393 [TBL] [Abstract][Full Text] [Related]
8. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer. Zhang WY; Liu YJ; He Y; Chen P J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354 [TBL] [Abstract][Full Text] [Related]
9. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
10. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859 [TBL] [Abstract][Full Text] [Related]
12. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Li JH; Xiao X; Zhang YN; Wang YM; Feng LM; Wu YM; Zhang YX Gynecol Oncol; 2011 Jan; 120(1):145-51. PubMed ID: 20947150 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-96-5p Facilitates the Viability, Migration, and Invasion and Suppresses the Apoptosis of Cervical Cancer Cells byNegatively Modulating SFRP4. Zhang H; Chen R; Shao J Technol Cancer Res Treat; 2020; 19():1533033820934132. PubMed ID: 32527205 [TBL] [Abstract][Full Text] [Related]
15. STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells. Liao XH; Xiang Y; Yu CX; Li JP; Li H; Nie Q; Hu P; Zhou J; Zhang TC Oncotarget; 2017 Feb; 8(9):15763-15774. PubMed ID: 28178652 [TBL] [Abstract][Full Text] [Related]
16. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer. Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma. Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD. Kim H; Choi H; Lee SK Cancer Lett; 2015 Jan; 356(2 Pt B):733-42. PubMed ID: 25449437 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer. Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]